Combination chemotherapy in the treatment of breast cancer patients with metastatic brain involvement and a poor prognosis

Cover Page

Cite item

Full Text

Abstract

Radiotherapy (RT) is a standard treatment for breast cancer (BC) patients with metastatic brain involvement. All patients (n = 15) had already received chemotherapy (CT) for the underlying disease when they were found to have brain metastases. To develop effective CT regimens for patients with recurrent brain metastases, who have received RT to the brain, is a serious problem. Combination CT with gemcitabine and cisplatin showed a high efficacy (complete and partial regressions were achieved in 47.7% of cases) and fair survival rates (median 10 months) in a group of patients with BC brain metastases and a poor prognosis.

About the authors

D. R. Naskhletashvili

N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow

Author for correspondence.
Email: Nas-david@yandex.ru
Russian Federation

A. Kh. Bekyashev

N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow

Russian Federation

V. A. Aleshin

N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow

Russian Federation

D. M. Belov

N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow

Russian Federation

E. A. Moskvina

N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow

Russian Federation

E. G. Chmutin

N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow

Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2011


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 36991 от  21.07.2009.